Home/Filings/4/0001179110-17-006746
4//SEC Filing

Allergan plc 4

Accession 0001179110-17-006746

CIK 0001578845operating

Filed

May 4, 8:00 PM ET

Accepted

May 5, 6:34 PM ET

Size

10.1 KB

Accession

0001179110-17-006746

Insider Transaction Report

Form 4
Period: 2017-05-03
Transactions
  • Tax Payment

    Ordinary Shares, par value $0.0001

    2017-05-03$243.76/sh668$162,8322,579 total
  • Exercise/Conversion

    Ordinary Shares, par value $0.0001

    2017-05-04$245.25/sh+17,693$4,339,20820,272 total
  • Exercise/Conversion

    Phantom Share Units

    2017-05-0417,6930 total
    Exercise: $245.25From: 2017-05-04Exp: 2017-05-04Ordinary Shares (17,693 underlying)
Holdings
  • Ordinary Shares, par value $0.0001

    (indirect: By Trust)
    1,767
  • Ordinary Shares, par value $0.0001

    (indirect: By Trust)
    10,165
Footnotes (2)
  • [F1]Includes restricted shares issued pursuant to the 2013 Incentive Award Plan of Allergan plc.
  • [F2]Represents the disposition of Phantom Share Units acquired under the Allergan, Inc. Deferred Directors' Fee Program. Per the program terms, the Phantom Share Units were settled 100% in ordinary shares of the Issuer upon termination of the Reporting Person's service on the Issuer's board of directors on May 4, 2017.

Issuer

Allergan plc

CIK 0001578845

Entity typeoperating
IncorporatedIreland

Related Parties

1
  • filerCIK 0001578845

Filing Metadata

Form type
4
Filed
May 4, 8:00 PM ET
Accepted
May 5, 6:34 PM ET
Size
10.1 KB